FDA Inspection
CGA LimitedCGA Limited – FDA Inspection, May 31, 2019
Record Details
This FDA Inspection record concerns CGA Limited, with an inspection on May 31, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 0e57a937-9a10-4077-8d33-0999e699b381
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1091328
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
- Enforcement
- Warning Letter
FDA Citations
10- 21 CFR 211.103Actual vs. theoretical yields not determined
- 21 CFR 211.105(a)Identification of containers, lines, equipment
- 21 CFR 211.166(b)Adequate number of batches on stability
- 21 CFR 211.101(d)Verification of component addition
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.160(b)(4)Establishment of calibration procedures
- 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.